Texas - AACE 2018 Annual Meeting

HOUSTON, TX US
August 3, 2018 to August 4, 2018

Welcome, and thank you for attending the Texas Chapter of AACE (TX-AACE) 2018 Annual Meeting & Texas Endocrine Surgical Symposium (TESS).

The Texas Chapter of AACE and TESS program committee has worked very hard to provide a relevant activity for the practicing clinical physician and other healthcare providers seeking education with an emphasis in endocrine disease.

This program has been planned to provide pertinent scientific and clinical information to help you achieve the best solutions in the diagnosis and therapeutic management of patients presenting with endocrine disease. Attendees will obtain updates in not only common and uncommon endocrine disorders, but also newer treatment modalities.

Providing exceptional patient care requires continuing high quality education. The American Association of Clinical Endocrinologists (AACE) was founded in 1991 by a visionary group of leaders to serve as the active voice for clinical endocrinologists. The impetus behind AACE's efforts has always been quality and cost-effective patient care for those with endocrine diseases and disorders. We hope that you will find this program of great value to you in your practice.

Target Audience

Endocrinologists, endocrine surgeons, and other health care professionals living in Texas who practice, or are interested in, the treatment of endocrine disease states.

Learning Objectives

  1. List site specific cancers that are associated with diabetes
  2. Discuss possible mechanisms on how diabetes confers increased risk
  3. Discuss controversies in regards to drugs used to treat diabetes and how they affect cancer risk/outcome
  4. Explain the pros and cons of various diets such as plant-based diets, low-carbohydrate diets, Mediterranean diet, balanced diet, low fat diet, etc.
  5. Understand nutrition treatment of diseases like obesity, diabetes, dyslipidemia and cardiovascular disease
  6. Counsel patients on the fundamentals of nutrition to address all aspects of health and disease
  7. Understand available lipid guidelines
  8. Understand differences between lipid guidelines
  9. Understand how to apply current guidelines for cardiovascular disease prevention
  10. Discuss the different available technologies to monitor glucose from the interstitial fluid and its technical advantages and limitations
  11. Integration of CGM with current therapies and upcoming applications
  12. Clinical scenarios for best practices of CGM
  13. Recognizing and managing endocrine conditions with atypical or unusual clinical presentations
  14. Increasing awareness of newer diagnostic testing modalities
  15. Increasing awareness of alternative testing and treatment approaches for common endocrine problems
  16. Recognize the imaging characteristics and clinical findings which accompany hypophysitis
  17. Describe the presentation and characteristics of more recently characterized forms of hypophysitis
  18. Discuss options for management of hypophysitis of different origins.
  19. Describe the technical advances in pituitary surgery over the last decade, particularly the endonasal endoscopic approach to sellar masses
  20. Discuss the predictors of remission/cure in patients with functional tumors including prolactinomas, somatotropinomas, and corticotropinomas
  21. Recognize the indications for surgical intervention of tumors that previously would have been treated medically, including prolactinomas
  22. Understand the relationship between testosterone replacement therapy and the effects on the prostate
  23. Be familiar with the FDA warnings for cardiovascular disease and indication for use of testosterone
  24. Understand the relationship between testosterone and male fertility
  25. Review the causes of non-specific and analyte-specific interferences affecting Endocrine Tests
  26. Discuss why test interferences should be suspected by the physician and not the laboratory
  27. Discuss approaches for confirming interference affecting a test result.
  28. Learn the new AJCC edition
  29. Understand the new Bethesda changes
  30. Become familiar new nomenclature for NIFTP
  31. Apply ATA 2015 Guidelines for extent of resection
  32. Use ATA guidelines in given clinical scenarios to determine evidence-based therapy recommendations
  33. Make recommendations for appropriate use of I131
  34. Determine the etiology and prevalence of vocal immobility related to thyroid disease and its surgery
  35. Be able to identify and quantify vocal immobility and its clinical consequences
  36. Understand management options including surgery for vocal fold immobility
  37. Learn how to prepare patients for surgery
  38. Learn how to treat a hypertensive crisis
  39. Learn how to approach patients with malignant pheochromocytoma and paraganglioma
  40. Classification of NEC
  41. Radiopharmaceuticals used in diagnoses of NEC
  42. Radiopharmaceuticals used in treatment of NEC
  43. Identify major risk factors for osteoporosis and osteoporotic fractures in patients with chronic kidney disease
  44. Recognize the recommended evaluation of skeletal health in patients with chronic kidney disease
  45. Assess the risk and benefits of pharmacological interventions to reduce fracture risk in patients with chronic kidney disease
  46. Examine the relationship of these adipokines and carotid intima thickness (cIMT) to insulin resistance and atherosclerosis in a Mexican-American population
  47. Understand the algorithm for evaluation of children with family history of MEN2
Additional information
Available for MOC Points?: 
No
Practice Area: 
Adrenal
Diabetes
Nutrition
Obesity
Pituitary
Reproductive
Thyroid
Course summary
Available credit: 
  • 12.00 AMA
  • 12.00 Attendance
Course opens: 
08/03/2018
Course expires: 
08/04/2019
Event starts: 
08/03/2018 - 7:00am
Event ends: 
08/04/2018 - 4:30pm
Cost:
$0.00

JW MARRIOTT HOUSTON
5150 WESTHEIMER ROAD
HOUSTON, TX, 77056

FRIDAY, AUGUST 3, 2018

7:00 – 8:00 AM

Continental Breakfast

8:00 - 8:30 AM

Welcome and Pre-Meeting assessment

Session 1 - Diabetes / Metabolism

8:30 - 9:05 AM

Diabetes and Cancer Risk: Is there a link?
Sonali Thosani, MD
Objectives

  1. List site specific cancers that are associated with diabetes
  2. Discuss possible mechanisms on how diabetes confers increased risk
  3. Discuss controversies in regards to drugs used to treat diabetes and how they affect cancer risk/outcome
9:05 - 9:40 AM

Nutrition: Overview of popular diets
Scott Isaacs, MD, FACP, FACE
Objectives

  1. Explain the pros and cons of various diets such as plant-based diets, low-carbohydrate diets, Mediterranean diet, balanced diet, low fat diet, etc.
  2. Understand nutrition treatment of diseases like obesity, diabetes, dyslipidemia and cardiovascular disease
  3. Counsel patients on the fundamentals of nutrition to address all aspects of health and disease
9:40 - 10:15 AM

Lipid Guidelines Comparison
Nicola Abate, MD
Objectives

  1. Understand available lipid guidelines
  2. Understand differences between lipid guidelines
  3. Understand how to apply current guidelines for cardiovascular disease prevention
10:15 - 10:45 AM

Break

10:45 - 11:20 AM

Continuous Glucose Monitoring: Are we there yet? Current uses and future directions 
Pablo Mora, MD, CDE, FACE
Objectives

  1. Discuss the different available technologies to monitor glucose from the interstitial fluid and its technical advantages and limitations
  2. Integration of CGM with current therapies and upcoming applications
  3. Clinical scenarios for best practices of CGM
11:20 - 11:55 AM

Some Cases from the Office: Next steps?
Brian Michael, MD, FACE, ECNU
Objectives

  1. Recognizing and managing endocrine conditions with atypical or unusual clinical presentations
  2. Increasing awareness of newer diagnostic testing modalities
  3. Increasing awareness of alternative testing and treatment approaches for common endocrine problems
12:30 - 2:00 PM

Lunch

Session 2 - Pituitary / Reproductive

2:00 - 2:35 PM

It's Not a Tumor: Update on hypophysitis
Susan Samson, MD, PhD, FRCPC, FACE
Objectives

  1. Recognize the imaging characteristics and clinical findings which accompany hypophysitis
  2. Describe the presentation and characteristics of more recently characterized forms of hypophysitis
  3. Discuss options for management of hypophysitis of different origins.
2:35 - 3:05 PM

Minimally Invasive Endoscopic Resection of Pituitary Tumors: A neurosurgeon’s perspective
Daniel Yoshor, MD
Objectives

  1. Describe the technical advances in pituitary surgery over the last decade, particularly the endonasal endoscopic approach to sellar masses
  2. Discuss the predictors of remission/cure in patients with functional tumors including prolactinomas, somatotropinomas, and corticotropinomas
  3. Recognize the indications for surgical intervention of tumors that previously would have been treated medically, including prolactinomas
3:05 - 3:40 PM

Break

3:40 - 4:15 PM

Controversies with the Diagnosis and Treatment of Hypogonadism
Mohit Khera, MD
Objectives

  1. Understand the relationship between testosterone replacement therapy and the effects on the prostate
  2. Be familiar with the FDA warnings for cardiovascular disease and indication for use of testosterone
  3. Understand the relationship between testosterone and male fertility
4:15 - 4:45 PM

Post Meeting Assessment

4:45 - 5:30 PM

Business Meeting

SATURDAY, AUGUST 4, 2018

6:45 – 7:40 AM

Continental Breakfast

7:40 - 8:05 AM

Welcome and Pre-Meeting assessment

Session 3 - Thyroid Section

8:05 - 8:40 AM

Interferences with Endocrine Tests
Carole Spencer, PhD, FACB, MTC
Objectives

  1. Review the causes of non-specific and analyte-specific interferences affecting Endocrine Tests
  2. Discuss why test interferences should be suspected by the physician and not the laboratory
  3. Discuss approaches for confirming interference affecting a test result.
8:40 - 9:45 AM

What's A NIFTP, Keeping Up to Date in Thyroid 2018
Kathleen Hands, MD, FACE, ECNU
Objectives

  1. Learn the new AJCC edition
  2. Understand the new Bethesda changes
  3. Become familiar new nomenclature for NIFTP
9:45 - 10:05 AM

Thyroid Cancer Case Review Panel
James Suliburk, MD, FACS
Objectives

  1. Apply ATA 2015 Guidelines for extent of resection
  2. Use ATA guidelines in given clinical scenarios to determine evidence-based therapy recommendations
  3. Make recommendations for appropriate use of I131
10:05 - 10:35 AM

Break

10:35 - 11:10 AM

Management of Vocal Paralysis - Raising Voices in Texas Endocrine Surgery
Kenneth Altman, MD, PhD, FACS
Objectives

  1. Determine the etiology and prevalence of vocal immobility related to thyroid disease and its surgery
  2. Be able to identify and quantify vocal immobility and its clinical consequences
  3. Understand management options including surgery for vocal fold immobility
11:10 - 12:00 PM

Panel Discussion

12:00 - 1:30 PM

Lunch

Session 4 - Adrenal / Bone

1:30 - 2:15 PM

Pheochromocytoma and Paraganglioma: Focus on therapeutics
Camillo Jimenez, MD
Objectives

  1. Learn how to prepare patients for surgery
  2. Learn how to treat a hypertensive crisis
  3. Learn how to approach patients with malignant pheochromocytoma and paraganglioma
2:15 - 2:45 PM

New Radio Pharmaceuticals in the Diagnosis and Treatment of Neuroendocrine Cancers
(NEC) (NON-CME)

Ebrahim Delpassand, MD, FACN, FACNM
Objectives

  1. Classification of NEC
  2. Radiopharmaceuticals used in diagnoses of NEC
  3. Radiopharmaceuticals used in treatment of NEC
2:45 - 3:20 PM

Bone Health in Patients with Chronic Kidney Disease: Evaluation and management
Naim Maalouf, MD
Objectives

  1. Identify major risk factors for osteoporosis and osteoporotic fractures in patients with chronic kidney disease
  2. Recognize the recommended evaluation of skeletal health in patients with chronic kidney disease
  3. Assess the risk and benefits of pharmacological interventions to reduce fracture risk in patients with chronic kidney disease
3:20 – 3:55 PM

Oral Abstract Presentations

3:20 – 3:35 PM

Novel Associations of Adipokines and Atherosclerotic Markers with Rising Levels of Insulin Resistance
in a Mexican-American Board

Sapna Naik, MD
Objectives

  1. Examine the relationship of these adipokines and carotid intima thickness (cIMT) to insulin resistance and atherosclerosis in a Mexican-American population
3:35 – 3:55 PM

Small Glands in Experienced Hands: Early thyroidectomy in pediatric patients with multiple endocrine neoplasia type 2 (MEN2)
Minerva A. Romero Arenas, MD, MPH
Objectives

  1. Understand the algorithm for evaluation of children with family history of MEN2
3:55 - 4:30 PM

Post-Meeting Assessment/Adjourn

JW MARRIOTT HOUSTON
5150 WESTHEIMER ROAD
HOUSTON, TX 77056
United States

Nicola Abate, MD
UTMB
Galveston, TX

Kenneth W. Altman, MD, PhD, FACS
Professor and Vice Chair for Clinical Affairs
Department of Otolaryngology - Head & Neck Surgery
Baylor College of Medicine
Houston, TX

Minerva A. Romero Arenas, MD, MPH
Assistant Professor of Surgery
The University of Texas Rio Grande Valley School of Medicine
Edinburg, TX

Ebrahim S. Delpassand, MD, FACNM
Chairman and Medical Director
Excel Diagnostics and Nuclear Oncology Center
Houston, TX

*Kathleen Hands, MD, FACE, ECNU
President, Texas Chapter AACE
Director/CEO Thyroid Center of South Texas
Adjunct Assistant Professor of Medicine
University Texas Health Science Center San Antonio
San Antonio, TX

Scott D. Isaacs, MD, FACP, FACE
Adjunct Instructor of Medicine
Emory University School of Medicine
Medical Director
Atlanta Endocrine Associates
Atlanta, GA

Camilo Jimenez, MD
Associate Professor
Department of Endocrine Neoplasia and Hormonal Disorders
Past Chair of the international Society for Pheochromocytoma and Paraganglioma Research Support
PRESSOR
The University of Texas MD Anderson Cancer Center
Houston, TX

Mohit Khera, MD, MBA, MPH
Associate Professor of Urology
Baylor College of Medicine
Houston, TX

Naim Maalouf, MD
Associate Professor of Medicine
University of Texas Southwestern Medical Center
Dallas, TX

Brian Michael, MD, FACE, ECNU
New Oxford, PA

Pablo Mora, MD, CDE, FACE
Staff Endocrinologist Dallas Diabetes Research Center at Medical City Dallas
Adjunct Associate Professor University of Texas Southwestern
Dallas, TX

Sapna Naik, MD
Resident Physician, Internal Medicine
University of Texas Health Science Center at Houston
McGovern Medical School
Houston, TX

*Susan Samson, MD, PhD, FRCPC, FACE
Associate Professor of Medicine
Baylor College of Medicine
Endocrinology Fellowship Director
Houston, TX

Carole Spencer, PhD, FACB, MTC
Professor of Medicine
University of Southern California
Los Angeles, CA

*James Suliburk, MD, FACS
Associate Professor of Surgery
Chief of Endocrine Surgery
Baylor College of Medicine
Michael E DeBakey Department of Surgery
Houston, TX

Sonali Thosani, MD
Assistant Professor
Department of Endocrine Neoplasia & Hormonal Disorders
UT-MD Anderson Cancer Center
Houston, TX

Daniel Yosher, MD
Professor and Chairman,
Department of Neurosurgery
Baylor College of Medicine
Houston, TX

* Indicates both a member of the Program Committee and faculty.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Association of Clinical Endocrinologists (AACE) and the Texas Chapter of AACE. The American Association of Clinical Endocrinologists (AACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Association of Clinical Endocrinologists (AACE) designates this live activity for a maximum of 12 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 12.00 AMA
  • 12.00 Attendance

Accreditation Period

Course opens: 
08/03/2018
Course expires: 
08/04/2019

Price

Cost:
$0.00
Please login or register to take this course.